Medivation Inc (MDVN)

62.55
0.09 0.14
NASDAQ : Health Care
Prev Close 62.64
Open 62.49
Day Low/High 62.27 / 63.01
52 Wk Low/High 26.41 / 63.34
Volume 759.23K
Avg Volume 2.49M
Exchange NASDAQ
Shares Outstanding 164.62M
Market Cap 10.39B
EPS 1.50
P/E Ratio 39.94
Div & Yield N.A. (N.A)

Latest News

Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta

Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta

At least one company follower believes the divestiture of Shire's Neurology division for as much as $13 billion would be a logical next move.

Cramer: 11 Reasons Why the Market Turned

Cramer: 11 Reasons Why the Market Turned

All of these add up to a level of insecurity on the part of sidelined money.

Cramer: 5 Market Themes for the Rest of 2016

Cramer: 5 Market Themes for the Rest of 2016

It's a pretty broad spectrum, but they've definitely arrived.

Medivation Tries to Prove Its Worth

Medivation Tries to Prove Its Worth

A call with investors Wednesday highlights drugs in the pipeline that could be attractive to bidders that reportedly include Sanofi, Pfizer and Celgene, among others.

Wall Street Closes Higher as Fed Doves Make Case for Waiting on Rates

Wall Street Closes Higher as Fed Doves Make Case for Waiting on Rates

A dovish Federal Reserve in June pushes equities, crude to close around session highs.

Stocks Add to Gains as Fed Stresses Prudence in Policy-Making

Stocks Add to Gains as Fed Stresses Prudence in Policy-Making

Stocks add to gains by late afternoon Wednesday after the Federal Reserve's June meeting minutes confirm members' prudent approach to monetary policy.

Crude Turns Lower Again as Brexit Worries Weigh on Markets

Crude Turns Lower Again as Brexit Worries Weigh on Markets

Crude oil returns to the red by late Wednesday morning, reversing a brief recovery, as stocks turn mixed.

Medivation (MDVN) Stock Up on Potential Sanofi Deal

Medivation (MDVN) Stock Up on Potential Sanofi Deal

An agreement by Medivation (MDVN) to share confidential information with French company Sanofi (SNY) has led to speculation of a potential merger.

Stock Futures Set Up for Another Decline as Crude Tumbles, Trade Gap Widens

Stock Futures Set Up for Another Decline as Crude Tumbles, Trade Gap Widens

Stock futures set up Wall Street for another slide on Wednesday as Brexit fears pull crude oil lower.

Medivation Shares Spike as Company Opens Door to Full-Fledged Auction

Medivation Shares Spike as Company Opens Door to Full-Fledged Auction

The company's shares were up nearly 2% in after hours trading.

Stocks Feeling the Pressure of 'Brexit', Italian Banks Weakness

Stocks Feeling the Pressure of 'Brexit', Italian Banks Weakness

There are renewed worries about Brexit as the British pound has fallen to a new 30 year low.

REMINDER: Medivation To Host Conference Call And Webcast Providing Detailed Review Of Talazoparib On July 6, 2016

REMINDER: Medivation To Host Conference Call And Webcast Providing Detailed Review Of Talazoparib On July 6, 2016

Medivation, Inc. (Nasdaq:MDVN) today issued a reminder that it will host an investor conference call and live audio webcast on Wednesday, July 6, 2016 at 4:30 p.

July 6 Premarket Briefing: 10 Things You Should Know

July 6 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are lower Wednesday as European shares tumble and the British pound hits a new 31-year low.

An Auction Process Could Be on Medivation's Horizon

An Auction Process Could Be on Medivation's Horizon

The biopharmaceutical company has entered into confidentiality agreements with Sanofi and others.

Medivation Enters Into Confidentiality Agreements, Including With Sanofi

Medivation Enters Into Confidentiality Agreements, Including With Sanofi

Medivation, Inc. (NASDAQ:MDVN) today announced that it has entered into confidentiality agreements with a number of parties that have expressed interest in exploring a potential transaction and demonstrated that interest to...

Trade-Ideas: Medivation (MDVN) Is Today's

Trade-Ideas: Medivation (MDVN) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Medivation (MDVN) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

'Mad Money' Lightning Round: You Should Be Buying Visa

'Mad Money' Lightning Round: You Should Be Buying Visa

Cramer says Wynn is fantastic but he's avoiding Valeant.

Jim Cramer's 'Mad Money' Recap: Thank the Short-Sellers for This Continued Rally

Jim Cramer's 'Mad Money' Recap: Thank the Short-Sellers for This Continued Rally

When short-sellers get caught leaning the wrong way, that's a recipe for explosive moves to the upside, Cramer says.

5 Hot Stocks to Watch Right Now

5 Hot Stocks to Watch Right Now

Biotech stocks continue to dominate our top stock charts to watch.

What Tesaro's Cancer Drug Success Means for Medivation

What Tesaro's Cancer Drug Success Means for Medivation

Sanofi's $52.50 per share takeout offer for Medivation is looking increasingly unappealing.

16 Biopharma Companies Besides Medivation That Are Attractive Targets

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.

Sanofi to Exit Animal Care in $25 Billion Asset Swap With Boehringer

Sanofi to Exit Animal Care in $25 Billion Asset Swap With Boehringer

The Medivation bidder will swap its Merial animal care unit for Boehringer's over-the-counter operations and cash.

Glass Lewis Recommends Medivation's Stockholders Support The Company's Current Board

Glass Lewis Recommends Medivation's Stockholders Support The Company's Current Board

Medivation, Inc. (NASDAQ:MDVN) today announced that independent proxy advisory firm Glass, Lewis & Co.

Medivation's Letter To Stockholders

Medivation's Letter To Stockholders

Medivation, Inc. (NASDAQ:MDVN) today sent a letter to stockholders providing detailed information to correct the misleading claims Sanofi has made as part of its coercive efforts to acquire Medivation at an opportunistic,...

Sanofi's Likely Sweetener for Medivation Panned

Sanofi's Likely Sweetener for Medivation Panned

The French drugmaker is reportedly thinking about including a CVR in its $9.3 billion bid for Medivation, but the move is unlikely to be enough to entice the target's shareholders.

BioMarin Takeout Rumors Swirl, Industry Insiders Aren't Convinced

BioMarin Takeout Rumors Swirl, Industry Insiders Aren't Convinced

While some say Sanofi could make a bid for BioMarin, analysts aren't so convinced.

MEDIVATION INVESTIGATION ALERT - Andrews & Springer LLC Is Investigating Medivation, Inc. For Potential Breaches Of Fiduciary Duty - MDVN

MEDIVATION INVESTIGATION ALERT - Andrews & Springer LLC Is Investigating Medivation, Inc. For Potential Breaches Of Fiduciary Duty - MDVN

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Medivation, Inc.